Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	103.61	149.95	73.65
Graham Fair Price	-46.53	689.75	1290.09
PEG	1873.96	0.16	< 0.005
Price/Book	-3.54	0.40	0.42
Price/Cash Flow	381.39	25.06	5.21
Prices/Earnings	-231.68	-11.05	-3.33
Price/Sales	-24.19	2.33	3.07
Price/FCF	381.39	25.06	5.21
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-4.40	0.64	0.67
Operating Margin	-69.95	0.13	0.44
ROA	72.49	< 0.005	< 0.005
ROE	-0.03	< 0.005	70.92
ROIC	< 0.005	< 0.005	-60.48
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	-0.04	14.17
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	5.07	-0.62	-87.76
EPS QOQ	-4.24	0.71	-83.20
FCF QOQ	1.25	-0.80	-36.01
Revenue QOQ	-0.30	0.26	-12.11
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	433.93	610.96	40.80
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.83	0.83	-0.53
Quick Ratio	0.35	0.54	52.07
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1537.36	1524.17	-0.86
Cash	986.42	1068.63	8.33
Capex	-5.70	-4.26	25.32
Free Cash Flow	123.12	24.46	-80.13
Revenue	208.87	263.49	26.15
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.00	0.00	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	67.69	137.74	103.48
Naive Interpretation	Member

06 - Financial Health · Bad

Rating